RE:How high will this go?Interesting thoughts for discussion...my take is we get a joint collaboration/partnership with a Pharm company for their Ketarex distribution product and a possible spin-out as well for their other multi clinical trial products. Also, notwithstanding a spin-out for their 49% ownership of Sairiyo subsidary, going to trails in Australia and so after in the U.S. For share price, Im conservative, if we manage to get $1.25/share just on FDA approval within 7-10 days from announcement, I'd be pleased...may even rise later within 60 days to a high of $1.60+/share. Thereafter anyone's guess..My opinion...
First things first...we need that FDA approval...sooner rather than later..deadline is end of October 2024, but approval can easily come much sooner. Time will tell...